B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

IGF1R

MOLECULAR TARGET

insulin like growth factor 1 receptor

UniProt: P08069NCBI Gene: 348025 compounds

IGF1R (insulin like growth factor 1 receptor) is targeted by 25 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting IGF1R

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1foretinib4.3476
2tozasertib4.3375
3ceritinib4.1965
4brigatinib3.8144
5nintedanib3.6136
6tae 6843.4330
7fedratinib3.4029
8entrectinib3.1823
9lestaurtinib3.0420
10r 4062.8316
11kw 24492.6413
12linsitinib2.6413
13bms 7548072.309
14asp 30262.087
15maleimide1.956
16bastadin 71.956
17pf 038147351.795
18ilorasertib1.795
19norlichexanthone1.795
20anilinopyrimidine11.795
21Crizotinib1.102
22Quercetin0.691
23ly2940020.691
24Masoprocol0.691
25bdb 3 6 4 1r 4s 5 oxa 2 aza bicyclo 2 2 1 heptan 2 yl piperidin 1 yl 4 methyl 1h ben0.691

About IGF1R as a Drug Target

IGF1R (insulin like growth factor 1 receptor) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 25 compounds with documented IGF1R interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

IGF1R inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.